{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:11:49Z","timestamp":1785161509167,"version":"3.55.0"},"reference-count":197,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>\n                    The human microbiome is now recognized as an active and dynamic participant in cancer biology rather than a passive bystander. Increasing evidence demonstrates that microbial dysbiosis contributes to tumor initiation and progression through chronic inflammation, genotoxic toxin production, metabolic reprogramming, immune modulation, and direct reshaping of the tumor microenvironment. Specific microbial factors including colibactin,\n                    <jats:italic>Bacteroides fragilis<\/jats:italic>\n                    toxin, CagA, and\n                    <jats:italic>Fusobacterium<\/jats:italic>\n                    adhesins intersect with canonical oncogenic pathways. Linking microbial activity to genomic instability and immune evasion. Microbial metabolites such as secondary bile acids, lipopolysaccharide, hydrogen sulfide, and short-chain fatty acids further regulate epithelial integrity, epigenetic remodeling, and immune cell dynamics in a context-dependent manner. Beyond tumorigenesis, the microbiome critically determines therapeutic response. Microbial communities influence chemotherapy and radiotherapy outcomes and shape immune checkpoint blockade efficacy through immune priming, antigen mimicry, and microbiome\u2013metabolite\u2013immune interactions that govern treatment responsiveness. Emerging preclinical studies and early clinical investigations suggest that microbiome modulation, including fecal microbiota transplantation (FMT), may help restore immunotherapy sensitivity in selected patients; however, larger controlled trials are required to establish efficacy, safety, and long-term clinical benefits. This review integrates mechanistic, preclinical, and clinical evidence across microbiome-driven carcinogenesis, tumor microenvironment remodeling, drug metabolism, and biomarker development. Advances in circulating microbial DNA profiling and machine learning\u2013based diagnostics further position the microbiome as both a mechanistic driver and a translational target in precision oncology. We also discuss key challenges, including interindividual variability, standardization of methodologies, and the need for personalized therapeutic strategies. Collectively, understanding and harnessing microbiome\u2013cancer interactions hold significant promise for improving cancer diagnosis, treatment, and patient outcomes.\n                  <\/jats:p>","DOI":"10.3389\/fcell.2026.1844436","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:39:37Z","timestamp":1783057177000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Microbiome and cancer: mechanistic insights, diagnostic potential, and therapeutic strategies"],"prefix":"10.3389","volume":"14","author":[{"given":"Vivek","family":"Kumar","sequence":"first","affiliation":[{"name":"USF Center for Microbiome Research, Microbiomes Institute, USF Florida","place":["Tampa, FL, United States"]},{"name":"Center of Excellence in Aging and Brain Repair, University of South Florida Morsani College of Medicine","place":["Tampa, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Chaudhary","sequence":"additional","affiliation":[{"name":"Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Gautam","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sharda University","place":["Greater Noida, Uttar Pradesh, India"]},{"name":"Department of Blood, Sharda University","place":["Greater Noida, Uttar Pradesh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, IILM University","place":["Greater Noida, Uttar Pradesh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, IILM University","place":["Greater Noida, Uttar Pradesh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/microorganisms12030430","article-title":"Next-generation probiotics as novel therapeutics for improving human health: current trends and future perspectives","volume":"12","author":"Abouelela","year":"2024","journal-title":"Microorganisms"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.3390\/pharmaceutics14102100","article-title":"Salmonella as a promising curative tool against cancer","volume":"14","author":"Aganja","year":"2022","journal-title":"Pharmaceutics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/biom15060879","article-title":"Probiotics and cancer: mechanistic insights and organ-specific impact","volume":"15","author":"Ahmad","year":"2025","journal-title":"Biomolecules"},{"key":"B4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.acr.2022.02.007","article-title":"Chemotherapy induced gastrointestinal toxicities","volume":"155","author":"Akbarali","year":"2022","journal-title":"Adv. Cancer Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12934-025-02838-2","article-title":"Bacteria-based immunosuppressive tumor microenvironment reprogramming: a promising dawn in cancer therapy","volume":"24","author":"Akbariqomi","year":"2025","journal-title":"Microb. Cell. Factories"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s12602-025-10573-8","article-title":"Harnessing the microbiome: CRISPR-based gene editing and antimicrobial peptides in combating antibiotic resistance and cancer","volume":"17","author":"Amen","year":"2025","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B7","doi-asserted-by":"publisher","first-page":"52147","DOI":"10.26717\/BJSTR.2024.60.009387","article-title":"Microbiome and treatment resistance in colorectal cancer: mechanisms and solutions","volume":"60","author":"Ara\u00fajo-Filho","year":"2024","journal-title":"Biomed. J. Sci. and Tech. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.1224820","article-title":"Intestinal inflammation targets cancer-inducing activity of the microbiota","volume":"338","author":"Arthur","year":"2012","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"30502098251415109","DOI":"10.1177\/30502098251415109","article-title":"Gut-microbiome interactions: characterization, therapeutic implications and machine learning","volume":"19","author":"Ayivi-Tosuh","year":"2026","journal-title":"Sage Open Pathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","article-title":"The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL","volume":"574","author":"Aykut","year":"2019","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12938-025-01487-1","article-title":"Artificial intelligence at the gut\u2013oral microbiota frontier: mapping machine learning tools for gastric cancer risk prediction","volume":"24","author":"Azhdarimoghaddam","year":"2025","journal-title":"Biomed. Eng. OnLine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41522-025-00883-8","article-title":"Gut microbiome\u2013driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming","volume":"12","author":"Bautista","year":"2026","journal-title":"Npj Biofilms Microbiomes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e135597","DOI":"10.1172\/jci.insight.135597","article-title":"Commensal bacteria stimulate antitumor responses via T cell cross-reactivity","volume":"5","author":"Bessell","year":"2020","journal-title":"JCI Insight"},{"key":"B16","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41416-021-01365-2","article-title":"Tumour neoantigen mimicry by microbial species in cancer immunotherapy","volume":"125","author":"Boesch","year":"2021","journal-title":"Br. J. Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"534606","DOI":"10.1101\/2023.03.28.534606","article-title":"The immune response to a fungus in pancreatic cancer samples","volume":"3","author":"Brayer","year":"2023","journal-title":"bioRxiv Prepr. Serv. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2374954","DOI":"10.1080\/2162402X.2024.2374954","article-title":"Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors","volume":"13","author":"Bredon","year":"2024","journal-title":"OncoImmunology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jff.2014.10.029","article-title":"Galacto-oligosaccharides and colorectal cancer: feeding our intestinal probiome","volume":"12","author":"Bruno-Barcena","year":"2015","journal-title":"J. Funct. Foods"},{"key":"B21","doi-asserted-by":"publisher","first-page":"109893","DOI":"10.1016\/j.isci.2024.109893","article-title":"Unveiling the intratumoral microbiota within cancer landscapes","volume":"27","author":"Che","year":"2024","journal-title":"iScience"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3389\/fimmu.2020.01088","article-title":"Looking for the optimal PD-1\/PD-L1 inhibitor in cancer treatment: a comparison in basic structure, function, and clinical practice","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12967-025-06209-8","article-title":"Distinctive circulating microbial metagenomic signatures in the plasma of patients with lung cancer and their potential value as molecular biomarkers","volume":"23","author":"Chen","year":"2025","journal-title":"J. Transl. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12929-025-01208-9","article-title":"Microbiome modulation of tumorigenesis and immune responses","volume":"33","author":"Chen","year":"2026","journal-title":"J. Biomed. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1136\/gutjnl-2020-321153","article-title":"The role of gut microbiota in cancer treatment: friend or foe?","volume":"69","author":"Cheng","year":"2020","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41522-025-00882-9","article-title":"CRISPR-engineered microbiome: living therapeutics revolutionize blood cancer immunotherapy","volume":"12","author":"Cheng","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1017\/erm.2025.10026","article-title":"Polyamine metabolism in cancer: drivers of immune evasion, ferroptosis and therapy resistance","volume":"27","author":"Chenna","year":"2025","journal-title":"Expert Rev. Mol. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"115332","DOI":"10.1016\/j.addr.2024.115332","article-title":"Novel strategies for modulating the gut microbiome for cancer therapy","volume":"210","author":"Cho","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/SPC.0000000000000134","article-title":"Probiotics to prevent gastrointestinal toxicity from cancer therapy: an interpretive review and call to action","volume":"9","author":"Ciorba","year":"2015","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/microorganisms13092147","article-title":"Human microbiome as an immunoregulatory axis: mechanisms, dysbiosis, and therapeutic modulation","volume":"13","author":"Cort\u00e9s","year":"2025","journal-title":"Microorganisms"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","article-title":"Microbiome and cancer","volume":"39","author":"Cullin","year":"2021","journal-title":"Cancer Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.3390\/ijms24043074","article-title":"Antibiotic-therapy-induced gut dysbiosis affecting gut microbiota-brain axis and cognition: restoration by intake of probiotics and synbiotics","volume":"24","author":"Dahiya","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","article-title":"Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects","volume":"45","author":"Daill\u00e8re","year":"2016","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","first-page":"675","DOI":"10.4161\/19490976.2014.969989","article-title":"The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment","volume":"5","author":"Dalmasso","year":"2014","journal-title":"Gut Microbes"},{"key":"B35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti\u2013PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2320291","DOI":"10.1080\/19490976.2024.2320291","article-title":"The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance","volume":"16","author":"de Oliveira Alves","year":"2024","journal-title":"Gut Microbes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","article-title":"The warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation","volume":"48","author":"Donohoe","year":"2012","journal-title":"Mol. Cell."},{"key":"B38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41579-021-00551-6","article-title":"Tumour cells show off bacterial peptides","volume":"19","author":"Du Toit","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41591-020-0908-2","article-title":"Colibactin DNA-damage signature indicates mutational impact in colorectal cancer","volume":"26","author":"Dziuba\u0144ska-Kusibab","year":"2020","journal-title":"Nat. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/microorganisms14020387","article-title":"Basic microbiome analysis: analytical steps from sampling to sequencing","volume":"14","author":"Ece","year":"2026","journal-title":"Microorganisms"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e472902","DOI":"10.1200\/EDBK-25-472902","article-title":"Gut microbiota in immuno-oncology: a practical guide for medical oncologists with a focus on antibiotics stewardship","volume":"45","author":"Elkrief","year":"2025","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e02706-20","DOI":"10.1128\/mbio.02706-20","article-title":"Fusobacterium nucleatum secretes outer membrane vesicles and promotes intestinal inflammation","volume":"12","author":"Engevik","year":"2021","journal-title":"mBio"},{"key":"B43","doi-asserted-by":"publisher","first-page":"18586","DOI":"10.1074\/jbc.RA119.010950","article-title":"Gut microbial \u03b2-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens","volume":"294","author":"Ervin","year":"2019","journal-title":"J. Biol. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1126\/science.aax0701","article-title":"Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage","volume":"369","author":"Fluckiger","year":"2020","journal-title":"Science"},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2023-329543","volume-title":"Lactobacillus gallinarum-derived Metabolites Boost anti-PD1 Efficacy in Colorectal Cancer by Inhibiting Regulatory T Cells Through Modulating IDO1\/Kyn\/AHR Axis","author":"Fong","year":"2023"},{"key":"B46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/PPO.0000000000000048","article-title":"Microbiome, inflammation, and cancer","volume":"20","author":"Francescone","year":"2014","journal-title":"Cancer J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/cancers17030368","article-title":"Unraveling the role of Fusobacterium nucleatum in colorectal cancer: molecular mechanisms and pathogenic insights","volume":"17","author":"Galasso","year":"2025","journal-title":"Cancers"},{"key":"B49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11912-024-01622-6","article-title":"Role of the microbiome and diet for response to cancer checkpoint immunotherapy: a narrative review of clinical trials","volume":"27","author":"Gamrath","year":"2025","journal-title":"Curr. Oncol. Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.synbio.2022.01.005","article-title":"Increasing prediction performance of colorectal cancer disease status using random forests classification based on metagenomic shotgun sequencing data","volume":"7","author":"Gao","year":"2022","journal-title":"Synthetic Syst. Biotechnol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1111\/j.1462-5822.2007.00939.x","article-title":"Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis","volume":"9","author":"Ge","year":"2007","journal-title":"Cell. Microbiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/gutjnl-2017-313789","article-title":"Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction","volume":"67","author":"Gerassy-Vainberg","year":"2018","journal-title":"Gut"},{"key":"B54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","first-page":"59070","DOI":"10.18632\/oncotarget.10887","article-title":"The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma","volume":"7","author":"Goto","year":"2016","journal-title":"Oncotarget"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1126\/science.abc9113","article-title":"Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy","volume":"373","author":"Griffin","year":"2021","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1016\/j.medmic.2020.100027","article-title":"Fecal microbiota transplantation: uses, questions, and ethics","volume":"6","author":"Grigoryan","year":"2020","journal-title":"Med. Microecology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"7927","DOI":"10.1096\/fj.201903266RR","article-title":"Cytotoxic necrotizing factor 1 promotes bladder cancer angiogenesis through activating RhoC","volume":"34","author":"Guo","year":"2020","journal-title":"FASEB J. Official Publ. Fed. Am. Soc. Exp. Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/agm2.12359","article-title":"Intratumoral microbiota as cancer therapeutic target","volume":"7","author":"Guo","year":"2024","journal-title":"Aging Med. Milt. (N.S.W)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.chom.2013.11.004","article-title":"Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial HemolysinA-Dependent killing of NK cells","volume":"14","author":"Gur","year":"2013","journal-title":"Cell. Host and Microbe"},{"key":"B61","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","article-title":"Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack","volume":"42","author":"Gur","year":"2015","journal-title":"Immunity"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e1581531","DOI":"10.1080\/2162402X.2019.1581531","article-title":"Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1","volume":"8","author":"Gur","year":"2019","journal-title":"Oncoimmunology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/nu5061869","article-title":"Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology","volume":"5","author":"Hardy","year":"2013","journal-title":"Nutrients"},{"key":"B64","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2183\/pjab.93.013","article-title":"Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer","volume":"93","author":"Hatakeyama","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B, Phys. Biol. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.3390\/cancers14215317","article-title":"Gut microbiota and tumor immune escape: a new perspective for improving tumor immunotherapy","volume":"14","author":"He","year":"2022","journal-title":"Cancers"},{"key":"B66","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41568-022-00473-2","article-title":"Polyamines in cancer: integrating organismal metabolism and antitumour immunity","volume":"22","author":"Holbert","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"433","DOI":"10.5217\/ir.2023.00019","article-title":"Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a review","volume":"21","author":"Hwang","year":"2023","journal-title":"Intestinal Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41467-021-21162-y","article-title":"Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells","volume":"12","author":"Iftekhar","year":"2021","journal-title":"Nat. Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/ijc.29488","article-title":"Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway","volume":"137","author":"Ito","year":"2015","journal-title":"Int. J. Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"100829","DOI":"10.1016\/j.neo.2022.100829","article-title":"Microbiota-driven mechanisms at different stages of cancer development","volume":"32","author":"Ivleva","year":"2022","journal-title":"Neoplasia"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1002\/mco2.420","article-title":"Probiotics, prebiotics, and postbiotics in health and disease","volume":"4","author":"Ji","year":"2023","journal-title":"MedComm"},{"key":"B73","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/ol.2024.14221","article-title":"Gut microbiota influences the efficiency of immune checkpoint inhibitors by modulating the immune system (review)","volume":"27","author":"Jiang","year":"2024","journal-title":"Oncol. Lett."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/cncr.31907","article-title":"A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma","volume":"125","author":"Jiang","year":"2019","journal-title":"Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1136\/gutjnl-2023-330291","article-title":"Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+ T cells","volume":"72","author":"Kang","year":"2023","journal-title":"Gut"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e70029","DOI":"10.1002\/cnr2.70029","article-title":"The role of microbiome and probiotics in chemo-radiotherapy-induced diarrhea: a narrative review of the current evidence","volume":"7","author":"Khorashadizadeh","year":"2024","journal-title":"Cancer Rep."},{"key":"B77","doi-asserted-by":"publisher","first-page":"101296","DOI":"10.1016\/j.smim.2019.101296","article-title":"CEACAM1 structure and function in immunity and its therapeutic implications","volume":"42","author":"Kim","year":"2019","journal-title":"Seminars Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/biology10030219","article-title":"Microbiome markers of pancreatic cancer based on bacteria-derived extracellular vesicles acquired from blood samples: a retrospective propensity score matching analysis","volume":"10","author":"Kim","year":"2021","journal-title":"Biology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3390\/cancers17071252","article-title":"Optimizing cancer treatment through gut microbiome modulation","volume":"17","author":"Kim","year":"2025","journal-title":"Cancers"},{"key":"B80","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","article-title":"Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment","volume":"14","author":"Kostic","year":"2013","journal-title":"Cell. Host and Microbe"},{"key":"B81","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13027-025-00676-w","article-title":"Targeting Fusobacterium nucleatum in colorectal cancer: therapeutic strategies and future directions","volume":"20","author":"Kowsarkhizi","year":"2025","journal-title":"Infect. Agents Cancer"},{"key":"B82","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-981-13-3705-5_14","article-title":"Techniques\/tools to study epigenetic biomarkers in human cancer detection","volume-title":"Biomedical Engineering and Its Applications in Healthcare","author":"Kumar","year":"2019"},{"key":"B83","first-page":"49","article-title":"Next-generation sequencing and genomic data analysis","volume-title":"Unraveling New Frontiers and Advances in Bioinformatics","author":"Kumar","year":""},{"key":"B84","first-page":"77","article-title":"Metagenomics and microbiome analysis","volume-title":"Unraveling New Frontiers and Advances in Bioinformatics","author":"Kumar","year":""},{"key":"B85","doi-asserted-by":"publisher","first-page":"104299","DOI":"10.1016\/j.jpet.2026.104299","article-title":"Epigenetics and the gut\u2013brain axis: insights into DNA methylation, aging, and alzheimer disease","volume":"393","author":"Kumar","year":"2026","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B86","doi-asserted-by":"publisher","first-page":"102557","DOI":"10.1016\/j.tranon.2025.102557","article-title":"Exploring the role of the oral microbiome in saliva, sputum, bronchoalveolar fluid, and lung cancer tumor tissue: a systematic review","volume":"62","author":"Kwiatkowska","year":"2025","journal-title":"Transl. Oncol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"14554","DOI":"10.1038\/srep14554","article-title":"Local bacteria affect the efficacy of chemotherapeutic drugs","volume":"5","author":"Lehouritis","year":"2015","journal-title":"Sci. Rep."},{"key":"B88","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41522-025-00786-8","article-title":"Gut microbiota shapes cancer immunotherapy responses","volume":"11","author":"Lei","year":"2025","journal-title":"Npj Biofilms Microbiomes"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s11605-023-05654-4","article-title":"Gut barrier dysfunction and bacterial lipopolysaccharides in colorectal cancer","volume":"27","author":"Li","year":"2023","journal-title":"J. Gastrointest. Surg. Official J. Soc. Surg. Alimentary Tract"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2544169","DOI":"10.1080\/20002297.2025.2544169","article-title":"Microbial manipulators: fusobacterium nucleatum modulates the tumor immune microenvironment in colorectal cancer","volume":"17","author":"Li","year":"","journal-title":"J. Oral Microbiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s12094-024-03697-w","article-title":"Tumor microenvironment as a complex milieu driving cancer progression: a mini review","volume":"27","author":"Li","year":"","journal-title":"Clin. and Transl. Oncol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s42003-021-01815-w","article-title":"Entropy-driven binding of gut bacterial \u03b2-glucuronidase inhibitors ameliorates irinotecan-induced toxicity","volume":"4","author":"Lin","year":"2021","journal-title":"Commun. Biol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"102601","DOI":"10.1016\/j.redox.2023.102601","article-title":"Implications of hydrogen sulfide in colorectal cancer: mechanistic insights and diagnostic and therapeutic strategies","volume":"59","author":"Lin","year":"2023","journal-title":"Redox Biol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/onc.2011.308","article-title":"Phosphorylation of RelA\/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1","volume":"31","author":"Liu","year":"2012","journal-title":"Oncogene"},{"key":"B95","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/advances\/nmx009","article-title":"Butyrate: a double-edged sword for health?","volume":"9","author":"Liu","year":"2018","journal-title":"Adv. Nutr."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/jpm13101487","article-title":"Probiotics and probiotic-like agents against chemotherapy-induced intestinal mucositis: a narrative review","volume":"13","author":"L\u00f3pez-G\u00f3mez","year":"2023","journal-title":"J. Personalized Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","article-title":"Formation of propionate and butyrate by the human colonic microbiota","volume":"19","author":"Louis","year":"2017","journal-title":"Environ. Microbiol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1690374","DOI":"10.3389\/fimmu.2025.1690374","article-title":"Unveiling the interplay between microbiota and PD1\/PD-L1 axis in tumor immunity and immunotherapy","volume":"16","author":"Lu","year":"2025","journal-title":"Front. Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/biomedicines13020422","article-title":"Microbiome integrity enhances the efficacy and safety of anticancer drug","volume":"13","author":"Mafe","year":"2025","journal-title":"Biomedicines"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"B101","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccr.2013.08.013","article-title":"P53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer","volume":"24","author":"Marcel","year":"2013","journal-title":"Cancer Cell."},{"key":"B102","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"key":"B103","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbadis.2007.12.005","article-title":"Viruses associated with human cancer","volume":"1782","author":"McLaughlin-Drubin","year":"2008","journal-title":"Biochimica Biophysica Acta"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1647740","DOI":"10.3389\/fnut.2025.1647740","article-title":"Gut microbiome-mediated health effects of fiber and polyphenol-rich dietary interventions","volume":"12","author":"Meiners","year":"2025","journal-title":"Front. Nutr."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jamaoncol.2025.3377","article-title":"Oral bacterial and fungal microbiome and subsequent risk for pancreatic cancer","volume":"11","author":"Meng","year":"2025","journal-title":"JAMA Oncol."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-01917-x","article-title":"Gut microbiome signatures predict cognitive impairment in older cancer survivors","author":"Miller","year":"2025","journal-title":"GeroScience"},{"key":"B107","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41419-023-05560-2","article-title":"Potential links between the microbiota and T cell immunity determine the tumor cell fate","volume":"14","author":"Mohseni","year":"2023","journal-title":"Cell. Death and Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1136\/gutjnl-2018-316818","article-title":"The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British society of gastroenterology (BSG) and healthcare infection society (HIS) guidelines","volume":"67","author":"Mullish","year":"2018","journal-title":"Gut"},{"key":"B109","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41586-023-06081-w","article-title":"Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma","volume":"617","author":"Naghavian","year":"2023","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.21037\/atm-20-6427","article-title":"The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer","volume":"9","author":"Naqash","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1056\/NEJM199110173251604","article-title":"Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii","volume":"325","author":"Nomura","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1073\/pnas.0711183105","article-title":"Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse","volume":"105","author":"Ohnishi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B113","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.molimm.2014.02.020","article-title":"Mast cells as targets for immunotherapy of solid tumors","volume":"63","author":"Oldford","year":"2015","journal-title":"Mol. Immunol. Mast Cell. Biol. New Funct. Old Cell."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i7.106810","article-title":"Microbiome dysbiosis and immune checkpoint inhibitors: dual targets in hepatocellular carcinoma management","volume":"17","author":"Pamungkas","year":"2025","journal-title":"World J. Hepatology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mi.2014.44","article-title":"Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway","volume":"8","author":"Park","year":"2015","journal-title":"Mucosal Immunol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41586-023-06026-3","article-title":"Targeting PD-L2\u2013RGMb overcomes microbiome-related immunotherapy resistance","volume":"617","author":"Park","year":"2023","journal-title":"Nature"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1624539","DOI":"10.3389\/fnut.2025.1624539","article-title":"Probiotic-derived postbiotics: a perspective on next-generation therapeutics","volume":"12","author":"Pattapulavar","year":"2025","journal-title":"Front. Nutr."},{"key":"B118","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"B119","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13148-025-02012-w","article-title":"Bacterial lipopolysaccharide alters DNA methylation in colorectal cancer cells","volume":"18","author":"Permain","year":"2025","journal-title":"Clin. Epigenetics"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1296447","DOI":"10.3389\/fmicb.2023.1296447","article-title":"Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases","volume":"14","author":"Petrariu","year":"2024","journal-title":"Front. Microbiol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41591-025-03693-9","article-title":"Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer","volume":"31","author":"Piccinno","year":"2025","journal-title":"Nat. Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","article-title":"Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli","volume":"580","author":"Pleguezuelos-Manzano","year":"2020","journal-title":"Nature"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e2205563","DOI":"10.1002\/advs.202205563","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Adv. Sci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12967-022-03512-6","article-title":"Molecular mimicry between tumor associated antigens and microbiota-derived epitopes","volume":"20","author":"Ragone","year":"2022","journal-title":"J. Transl. Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"100245","DOI":"10.1016\/j.medidd.2025.100245","article-title":"Microbiota-derived metabolites in cancer: dual roles in pathogenesis and opportunities for therapy","volume":"29","author":"Rajak","year":"2026","journal-title":"Med. Drug Discov."},{"key":"B126","doi-asserted-by":"publisher","first-page":"e70455","DOI":"10.1002\/cnr2.70455","article-title":"Exploring fecal microbiota transplantation: potential benefits, associated risks, and challenges in cancer treatment","volume":"9","author":"Ramesh","year":"2026","journal-title":"Cancer Rep."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3390\/microorganisms11051312","article-title":"Helicobacter pylori and its role in gastric cancer","volume":"11","author":"Reyes","year":"2023","journal-title":"Microorganisms"},{"key":"B128","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/d41586-021-00640-9","article-title":"Bacterial peptides presented on tumour cells could be immunotherapy targets","volume":"592","author":"Riemer","year":"2021","journal-title":"Nature"},{"key":"B129","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.3390\/cancers17193247","article-title":"Fusobacterium nucleatum and its impact on colorectal cancer chemoresistance: a meta-analysis of in vitro Co-Culture infections","volume":"17","author":"Risoen","year":"2025","journal-title":"Cancers"},{"key":"B130","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"B131","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","article-title":"Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-Cadherin\/\u03b2-Catenin signaling via its FadA adhesin","volume":"14","author":"Rubinstein","year":"2013","journal-title":"Cell. Host and Microbe"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3390\/microorganisms12061111","article-title":"Contribution of pks+ Escherichia coli (E. coli) to Colon carcinogenesis","volume":"12","author":"Sadeghi","year":"2024","journal-title":"Microorganisms"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s12672-025-03574-0","article-title":"Gut microbiota as a hidden modulator of chemotherapy: implications for colorectal cancer treatment","volume":"16","author":"Sadeghloo","year":"2025","journal-title":"Discov. Oncol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.3390\/ijms24032895","article-title":"Helicobacter pylori and gastric cancer: pathogenetic mechanisms","volume":"24","author":"Salvatori","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1200\/JCO.2024.42.16_suppl.593","article-title":"Evaluating gut microbiome as a biomarker of pathological complete response in patients with early locally advanced triple negative breast cancer (LA TNBC): a pilot study","volume":"42","author":"Sarfraz","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"e12630","DOI":"10.1200\/JCO.2025.43.16_suppl.e12630","article-title":"Gut microbiome and serum cytokines as biomarkers for pathological complete response (pCR) and recurrence free survival in early locally advanced triple negative breast cancer (LA TNBC) receiving neoadjuvant chemotherapy (NA) and immune checkpoint blocker (ICI): updated analysis from a pilot study","volume":"43","author":"Sarfraz","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.chom.2015.05.002","article-title":"Salmonella manipulation of host signaling pathways provokes cellular transformation associated with gallbladder carcinoma","volume":"17","author":"Scanu","year":"2015","journal-title":"Cell. Host and Microbe"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1704947","DOI":"10.3389\/fmicb.2025.1704947","article-title":"Editorial: fecal microbiota transplants: challenges in translating microbiome research to clinical applications","volume":"16","author":"Scarpellini","year":"2025","journal-title":"Front. Microbiol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"3","DOI":"10.20517\/mrr.2023.51","article-title":"Understanding the role of gut microfloral bifidobacterium in cancer and its potential therapeutic applications","volume":"3","author":"Sharma","year":"2024","journal-title":"Microbiome Res. Rep."},{"key":"B140","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5152\/tjg.2025.24810","article-title":"Gut microbiome diagnostic biomarkers for colorectal cancer","volume":"37","author":"Shen","year":"2025","journal-title":"Turkish J. Gastroenterology Official J. Turkish Soc. Gastroenterology"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000973","article-title":"Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance","volume":"8","author":"Shi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"B142","doi-asserted-by":"publisher","first-page":"9202","DOI":"10.1158\/0008-5472.CAN-09-1378","article-title":"Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease","volume":"69","author":"Showe","year":"2009","journal-title":"Cancer Res."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/j.1365-2036.2007.03281.x","article-title":"Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms","volume":"25","author":"Sifrim","year":"2007","journal-title":"Alimentary Pharmacol. and Ther."},{"key":"B144","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","article-title":"Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis","volume":"40","author":"Singh","year":"2014","journal-title":"Immunity"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2284857","DOI":"10.1080\/15384047.2023.2284857","article-title":"Lipopolysaccharide (LPS) stimulation of pancreatic ductal adenocarcinoma (PDAC) and macrophages activates the NLRP3 inflammasome that influences the levels of pro-inflammatory cytokines in a co-culture model","volume":"24","author":"Sivam","year":"2023","journal-title":"Cancer Biol. and Ther."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal bifidobacterium promotes antitumor immunity and facilitates anti\u2013PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"B147","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1038\/oncsis.2016.38","article-title":"An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis","volume":"5","author":"Sivaprakasam","year":"2016","journal-title":"Oncogenesis"},{"key":"B148","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"B149","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.3390\/jcm14113673","article-title":"A review of the influence of prebiotics, probiotics, synbiotics, and postbiotics on the human gut microbiome and intestinal integrity","volume":"14","author":"Smolinska","year":"2025","journal-title":"J. Clin. Med."},{"key":"B150","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4014\/jmb.2301.01031","article-title":"Anticancer effects of gut microbiota-derived short-chain fatty acids in cancers","volume":"33","author":"Son","year":"2023","journal-title":"J. Microbiol. Biotechnol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/cas.15208","article-title":"Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis","volume":"113","author":"Song","year":"2022","journal-title":"Cancer Sci."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/s41564-022-01226-5","article-title":"Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism","volume":"7","author":"Spanogiannopoulos","year":"2022","journal-title":"Nat. Microbiol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"key":"B154","doi-asserted-by":"publisher","first-page":"631552","DOI":"10.3389\/fcell.2021.631552","article-title":"The role of gut microbial \u03b2-Glucuronidase in estrogen reactivation and breast cancer","volume":"9","author":"Sui","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3892\/ijo.2024.5632","article-title":"Butyrate as a promising therapeutic target in cancer: from pathogenesis to clinic","volume":"64","author":"Sun","year":"2024","journal-title":"Int. J. Oncol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41423-019-0339-5","article-title":"Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis","volume":"17","author":"Takahashi-Kanemitsu","year":"2020","journal-title":"Cell. and Mol. Immunol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cmet.2011.05.012","article-title":"Thiazolidinediones regulate adipose lineage dynamics","volume":"14","author":"Tang","year":"2011","journal-title":"Cell. Metab."},{"key":"B158","doi-asserted-by":"publisher","first-page":"2569739","DOI":"10.1080\/19490976.2025.2569739","article-title":"Gut microbiome metagenomics in clinical practice: bridging the gap between research and precision medicine","volume":"17","author":"Tegegne","year":"2025","journal-title":"Gut Microbes"},{"key":"B159","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41698-024-00617-7","article-title":"A review of machine learning methods for cancer characterization from microbiome data","volume":"8","author":"Teixeira","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-08-4466","article-title":"GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon","volume":"69","author":"Thangaraju","year":"2009","journal-title":"Cancer Res."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41587-019-0193-0","article-title":"Continuous evolution of base editors with expanded target compatibility and improved activity","volume":"37","author":"Thuronyi","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1609889","DOI":"10.3389\/fonc.2025.1609889","article-title":"Interaction of intratumoral microbiota with the tumor immune microenvironment and its impact on cancer progression","volume":"15","author":"Tingting","year":"2025","journal-title":"Front. Oncol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1078-0432.CCR-11-2011","article-title":"Molecular pathways: involvement of helicobacter pylori\u2013triggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers","volume":"18","author":"Ushijima","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"B164","doi-asserted-by":"publisher","first-page":"00010","DOI":"10.1016\/j.tibtech.2026.01.010","article-title":"Engineering salmonella as an immune-metabolic modulator of the tumor microenvironment","author":"Varsha","year":"2026","journal-title":"Trends Biotechnol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/eurjpc\/zwad057","article-title":"Promotion of healthy nutrition in primary and secondary cardiovascular disease prevention: a clinical consensus statement from the european association of preventive cardiology","volume":"30","author":"Vassiliou","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"B167","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"Viaud","year":"2013","journal-title":"Science"},{"key":"B168","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1126\/science.1191175","article-title":"Alleviating cancer drug toxicity by inhibiting a bacterial enzyme","volume":"330","author":"Wallace","year":"2010","journal-title":"Science"},{"key":"B169","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bbamcr.2018.11.016","article-title":"Dual functions of STAT3 in LPS-induced angiogenesis of hepatocellular carcinoma","volume":"1866","author":"Wang","year":"2019","journal-title":"Biochimica Biophysica Acta (BBA) - Mol. Cell. Res."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1136\/gutjnl-2019-320105","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"B171","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ebiom.2019.03.070","article-title":"Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients","volume":"44","author":"Wardill","year":"2019","journal-title":"EBioMedicine"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gutjnl-2016-312766","article-title":"Quantitation of faecal fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia","volume":"66","author":"Wong","year":"2017","journal-title":"Gut"},{"key":"B173","doi-asserted-by":"publisher","first-page":"14979","DOI":"10.1073\/pnas.95.25.14979","article-title":"Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin","volume":"95","author":"Wu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/nm.2015","article-title":"A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses","volume":"15","author":"Wu","year":"2009","journal-title":"Nat. Med."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14785\/lymphosign-2016-0012","article-title":"Impact of prebiotics, probiotics, and gut derived metabolites on host immunity","volume":"4","author":"Wu","year":"2017","journal-title":"LymphoSign J."},{"key":"B176","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13027-025-00662-2","article-title":"Microbiota and metabolite profiles of saliva, oral swab and cancer tissue from patients with oral squamous cell carcinoma (OSCC)","volume":"20","author":"Wu","year":"2025","journal-title":"Infect. Agents Cancer"},{"key":"B177","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/19490976.2020.1739794","article-title":"Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not?","volume":"11","author":"Xiaoyu","year":"2020","journal-title":"Gut Microbes"},{"key":"B178","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.3390\/foods11182863","article-title":"Health benefits and side effects of short-chain fatty acids","volume":"11","author":"Xiong","year":"2022","journal-title":"Foods"},{"key":"B179","doi-asserted-by":"publisher","first-page":"e0006022","DOI":"10.1128\/cmr.00060-22","article-title":"Fecal microbiota transplantation: current challenges and future landscapes","volume":"37","author":"Yadegar","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"B180","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.molcel.2012.08.028","article-title":"Molecular machinery for insertion of tail-anchored membrane proteins into the endoplasmic reticulum membrane in mammalian cells","volume":"48","author":"Yamamoto","year":"2012","journal-title":"Mol. Cell."},{"key":"B181","doi-asserted-by":"publisher","first-page":"15347354221114100","DOI":"10.1177\/15347354221114100","article-title":"Research on gut microbiota-derived secondary bile acids in cancer progression","volume":"21","author":"Yang","year":"2022","journal-title":"Integr. Cancer Ther."},{"key":"B182","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41392-025-02335-3","article-title":"Microbiota in cancer: current understandings and future perspectives","volume":"11","author":"Yao","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"B183","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1182\/blood-2005-08-007377","article-title":"STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes","volume":"108","author":"Zhang","year":"2006","journal-title":"Blood"},{"key":"B185","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat. Immunol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/mco2.104","article-title":"NF-\u03baB signaling in inflammation and cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"MedComm"},{"key":"B187","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40164-022-00334-6","article-title":"Gut fungi enhances immunosuppressive function of myeloid-derived suppressor cells by activating PKM2-dependent glycolysis to promote colorectal tumorigenesis","volume":"11","author":"Zhang","year":"2022","journal-title":"Exp. Hematol. and Oncol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"e0139524","DOI":"10.1128\/msystems.01395-24","article-title":"Deep learning enabled integration of tumor microenvironment microbial profiles and host gene expressions for interpretable survival subtyping in diverse types of cancers","volume":"9","author":"Zhang","year":"","journal-title":"mSystems"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1411490","DOI":"10.3389\/fimmu.2024.1411490","article-title":"Harnessing microbial antigens as cancer antigens: a promising avenue for cancer immunotherapy","volume":"15","author":"Zhang","year":"","journal-title":"Front. Immunol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2024.14796","article-title":"Fungal influence on immune cells and inflammatory responses in the tumor microenvironment","volume":"29","author":"Zhang","year":"2025","journal-title":"Oncol. Lett."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1757513","DOI":"10.3389\/fimmu.2026.1757513","article-title":"Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"188490","DOI":"10.1016\/j.bbcan.2020.188490","article-title":"Role of gut microbiota in epigenetic regulation of colorectal cancer","volume":"1875","author":"Zhao","year":"2021","journal-title":"Biochimica Biophysica Acta (BBA) - Rev. Cancer"},{"key":"B193","doi-asserted-by":"publisher","first-page":"114985","DOI":"10.1016\/j.biopha.2023.114985","article-title":"Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: a review","volume":"164","author":"Zhao","year":"2023","journal-title":"Biomed. and Pharmacother. = Biomedecine and Pharmacother."},{"key":"B194","doi-asserted-by":"publisher","first-page":"15209","DOI":"10.1038\/s41598-021-94677-5","article-title":"Assessment of thoracic aorta in different cardiac phases in patients with non-aorta diseases using cardiac CT","volume":"11","author":"Zheng","year":"2021","journal-title":"Sci. Rep."},{"key":"B195","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12943-025-02513-5","article-title":"Gut microbiota reshaping the pancreatic cancer immune microenvironment: new avenues for immunotherapy","volume":"24","author":"Zheng","year":"2025","journal-title":"Mol. Cancer"},{"key":"B196","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-019-1236-x","article-title":"Longitudinal multi-omics of host\u2013microbe dynamics in prediabetes","volume":"569","author":"Zhou","year":"2019","journal-title":"Nature"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dote.12466","article-title":"Lipopolysaccharide-induced toll-like receptor 4 signaling in esophageal squamous cell carcinoma promotes tumor proliferation and regulates inflammatory cytokines expression","volume":"30","author":"Zu","year":"2017","journal-title":"Dis. Esophagus"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1844436\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:39:39Z","timestamp":1783057179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1844436\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":197,"alternative-id":["10.3389\/fcell.2026.1844436"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1844436","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"article-number":"1844436"}}